Back to search
Contrast Induced Nephropathy (CIN)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Contrast Induced Nephropathy (CIN) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Contrast Induced Nephropathy (CIN) trials you may qualify forContrast-induced nephropathy (CIN) is a common complication in high-risk patients undergoing percutaneous coronary intervention (PCI) due to exposure to iodinat…
The use of imaging is increasing in clinical practice, either for diagnosis or intervention. In these imaging processes, contrast medium (CM) is widely used. Ho…
The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit
This clinical trial evaluates whether continuing or withholding ACE inhibitors (specifically Ramipril) before coronary angiography affects the risk of contrast-…
Given the limited understanding of the impact of statin and N-acetyl cysteine use before angiography in preventing contrast-induced nephropathy (CIN), the objec…